Interagency Coordination in Drug Research and Regulation: Supplementary exhibits and index to parts 1 and 2Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use, drugs for mental illness, neonatal pharmacology, etc. |
Contents
| 310 | |
| 316 | |
| 321 | |
| 334 | |
| 340 | |
| 345 | |
| 346 | |
| 355 | |
| 501 | |
| 575 | |
| 604 | |
| 636 | |
| 643 | |
| 651 | |
| 666 | |
| 672 | |
| 367 | |
| 373 | |
| 392 | |
| 398 | |
| 407 | |
| 413 | |
| 430 | |
| 433 | |
| 455 | |
| 458 | |
| 678 | |
| 684 | |
| 692 | |
| 699 | |
| 705 | |
| 716 | |
| 722 | |
| 735 | |
| 751 | |
Other editions - View all
Common terms and phrases
action additional adequate adverse advertising agencies agents agranulocytosis Altafur amended American anemia animal tests animals antibiotics aplastic anemia approved Association Bureau of Medicine chemical chloramphenicol Chloromycetin cholesterol clinical investigations clinical testing Commissioner consumer Cosmetic Act Division doctors Dornwal dosage Drug Administration Drug Application Education efficacy established evaluation EXHIBIT experience FDA acknowledged FDA's Federal Food firm submitted food additives Food and Drug Government Hoffman-La Roche hospitals industry infections July labeling Laboratories Larrick letter manufacturer Marsilid Mediphone milligrams National NDA's October officer organization patients percent personnel pharmaceutical pharmacology physicians prescription problems professional proposed protection Public Health reactions recommendations regulations reports request Reserpine responsibility revised safety scientific scientists Secretary Senate side effects sponsor staff Stat statement subcommittee tablets teratogenic thalidomide therapeutic therapy tion toxicity treatment vitamin warning Welfare Zoxazolamine